A Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months

Clinical trial NCT05245552 · COMPLETED

Trial details

NCT number: NCT05245552
Sponsor: Sinovac Biotech Co., Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Seasonal Influenza

Start date: 2022-08-08
Primary completion: 2023-08-04
Enrollment: 217

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.